Cutler Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-400
Closed -$4K 4045
2022
Q4
$4K Sell
400
-2,000
-83% -$57.3K ﹤0.01% 3290
2022
Q3
$1K Hold
2,400
﹤0.01% 4510
2022
Q2
$5K Hold
2,400
﹤0.01% 3691
2022
Q1
$5K Buy
+2,400
New +$62.8K ﹤0.01% 4110
2021
Q3
Sell
-300
Closed -$1K 5869
2021
Q2
$1K Buy
+300
New +$6.01K ﹤0.01% 5271
2019
Q4
Sell
-6,100
Closed -$18K 4137
2019
Q3
$18K Buy
6,100
+500
+9% +$3.59K ﹤0.01% 2245
2019
Q2
$15K Buy
+5,600
New +$66.3K ﹤0.01% 2401
2018
Q2
Sell
-8,000
Closed -$10K 4371
2018
Q1
$10K Buy
8,000
+7,000
+700% +$100K ﹤0.01% 2785
2017
Q4
$3K Sell
1,000
-7,100
-88% -$100K ﹤0.01% 3942
2017
Q3
$26K Sell
8,100
-1,800
-18% -$37.1K ﹤0.01% 2868
2017
Q2
$17K Buy
9,900
+4,800
+94% +$115K ﹤0.01% 3576
2017
Q1
$3K Buy
5,100
+100
+2% +$1.92K ﹤0.01% 5110
2016
Q4
$20K Sell
5,000
-20,000
-80% -$394K ﹤0.01% 3464
2016
Q3
$10K Buy
+25,000
New +$584K ﹤0.01% 4198

Other funds holding EVH

Cutler Group's EVH Position: Q1 2023 in Review

Cutler Group sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 782 shares — an estimated $21K sold.

Cutler Group first reported a position in EVH in Q1 2016 and held it in 20 quarters. The position peaked at $446K in Q1 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

  • Cutler Group reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 782 Evolent Health shares in Q1 2023, an estimated $21K.
  • Cutler Group first reported a position in Evolent Health in Q1 2016 and held it in 20 quarters.
  • Cutler Group's Evolent Health position peaked at $446K in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.